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combined treatment are characterized by the significant cubic
trend (P = 0.00284 and P = 0.029, respectively). Changes of
miRNA-126 expression level during post-treatment follow-up
were not characterized by the definite trend and not correlated
with changes of other miRNAs expression level. It was shown
the significant correlation between miRNA-25 and miRNA-205
expression levels, but was not found the trend of these miRNAs
level changes.
Conclusion: The clinical utility of the circulating miR-19b and
miR-125b expression analysis from this study remains to be
validated in large cohorts of patients with different histological
types of tumors, at the different stage of disease and outcomes.
One of the criteria for inclusion in the group must be susceptibil-
ity and/or resistance to therapy.
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Background: Epithelial ovarian cancer frequently metastasizes
to the omentum, a process that requires pro-angiogenic activa-
tion of HOMECs by tumour -secreted factors in their microenvi-
ronment. We have previously shown that ovarian cancer cells
secrete a range of factors with possible roles in metastatic angio-
genesis including the lysosomal proteases cathepsin D (CD) and
cathepsin L (CL). However, the role of these proteases in ovarian
cancer metastasis to the omentum is not fully understood.
Aim: To investigate whether proliferative effects of CD and CL
are dependent on their catalytic activity in HOMECs.
To investigate the intracellular signalling kinases activated by
CD and CL.
Method: HOMEC proliferation was assessed by using a colori-
metric (WST1) assay. Potential signalling pathways were exam-
ined by phosphokinase array and ELISAs. pH experiments were
carried out examine whether the observed effects were due to
the catalytic activity of CD and CL.
Result: CD and CL (50 ng/ml) significantly increased HOMEC
proliferation to 141 ± 27% (p = 0.001, n = 50) and 151% ± 34%
(p = 0.001, n = 45) respectively vs. control (100%) 72 h post-
treatment. Inhibitors of CD and CL enzyme activity had no effect
on HOMEC proliferation and subsequent pH data suggest a non-
proteolytic mitogenic activity of these cathepsins. Both proteins
induced phosphorylation of ERK1/2, AKT and p38a to 2, 1.5
and 1.5 folds respectively relative to total levels (compared to
control).
Conclusion: CD and CL induced proliferation in HOMECs. CD
and CL may non- proteolytically contribute to pro-angiogenic
responses of the omental microvasculature. Induction of phos-
phorylation of proliferative kinases ERK1/2, AKTand p38a suggest
possible downstream signalling cascades of these proteins.
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RCC is one of the main problems in oncourology. MiRNA
expression profiles are highly specific for malignant tumors of
different locations, and can be used to detect pathological molec-
ular biomarkers and to develop the optimal treatment for each
patient. Selection of miRNAs associated with the formation and
development of malignant tumors in the kidney was performed
using computer databases miRWalk (http://www.ma.uni-hei-del-
berg.de/apps/zmf/mirwalk/) and miRBase (http://www.mir-base.
org/). Paired samples of tumor and histologically normal tissue
from 46 patients with RCC were studied. RNAwas isolated by phe-
nol–chloroform extraction and treated with RNase-free DNase
after isolation. MiRNA expression analysis was performed by
RT-qPCR using Applied Biosystems (USA) kits: TaqMan Micro-
RNA Assays, TaqMan MicroRNA Reverse Transcription Kit,
TaqMan Fast Universal PCR Master Mix (2x). RNU6B was used
as reference miRNA. Quantity alterations of 20 microRNAs (hsa-
miR-219, -203, -148a, -129, -9, -34a, -34b, -34c-3p, -127, -193a-5p,
-191, -17, -24 -2*, -339 -3p, -212, -375, -125b, -124a, -132, -137) were
determined in samples of tumor compared to normal tissue
biopsy from the kidney of each patient. It was shown that the
expression of studied miRNAs usually decreased in RCC tumors.
The largest decrease of expression was observed for miR-129,
which expression was10–350-fold reduced in 93% of the samples
(P < 0.05) with no change of expression in the remaining 7% of
cases. MiR-375 (80% of cases,10–270-fold decrease), miR-34b
(79% of cases, 10–60-fold decrease), miR-124a (70% of cases, 10–
200-fold decrease) also frequently showed reduced expression
in tumors. In addition to the aforementioned ones, it had been
shown that expression in the tumor compared with histologically
normal tissue from the same patient was significantly decreased
in more than half of the cases for miR-125b, miR-127, miR-203,
miR-34c-3p, miR-9. Despite the fact that in 50% of cases
decreased expression of miR-9 was detected, it was the only of
studied microRNA with a significant increase in the expression
in 21% of cases in 10–160 times (P < 0.05). Associations between
the expression of investigated miRNAs and gender and age were
not noted. Dealing with each miRNA alone, we could not detect
the dependence of expression alteration of 20 selected miRNAs
from the stage or degree of tumor differentiation of the studied
RCC samples. However, the analysis of the expression profile of
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